Category: St. Jude MedicalSyndicate content

Medtech trends: The most talked about device makers in August 2014

September 3, 2014 by Arezu Sarvestani

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.

chart

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

Study: St. Jude's FFR helps boost stenting over drug therapy alone

September 2, 2014 by Arezu Sarvestani

Researchers report that St. Jude Medical's fractional flow reserve technology helps slash adverse events, especially urgent revascularizations, compared with medical therapy alone.

Study: St. Jude's FFR tech helps cut adverse events in half

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Renal denervation isn't dead, despite Medtronic trial's failure

September 2, 2014 by Brad Perriello

The failure of Medtronic's Symplicity 3 trial doesn't mean the end of renal denervation in treated resistant hypertension, especially in Europe, but future studies face a high bar set by the Medtronic trial's sham control arm.

Renal denervation isn't dead, despite Medtronic trial's failure

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Judge agrees to toss ex-Biosense rep's suit in non-compete row with St. Jude Medical

August 27, 2014 by Brad Perriello

A federal judge agrees to toss a lawsuit filed against Johnson & Johnson's Biosense Webster by a former sales rep and her new employer, St. Jude Medical.

Judge agrees to toss ex-Biosense rep's suit in non-compete row with St. Jude Medical

St. Jude Medical says FDA clears Texas neuromodulation plant

August 27, 2014 by Brad Perriello

St. Jude Medical says the FDA cleared a 2009 warning letter issued over a plant in Plano, Texas, that makes neuromodulation devices.

St. Jude Medical says FDA clears Texas neuromodulation plant

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Allergan calls out Valeant on latest earnings report : The week in medtech M&A

August 13, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Valeant's hostile takeover hopes fade as Allergan war continues; Medtronic hires ex-Senators to lobby for Covidien deal; FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried; St. Jude closes $200M NeuroTherm buy; Medtronic-Covidien merger means tax hit for all stockholders, including execs

Report: Valeant's hostile takeover hopes fade as Allergan war continues

August 6, 2014 by Arezu Sarvestani

Allergan attacks activist investor's latest earnings report

BSX reveals federal probe of BridgePoint buy | Medtech legal news for the week of August 11, 2014

August 11, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Boston Scientific reveals federal probe of BridgePoint buy, sales; Court defines 'breast implant' in Dow Corning's $2B product liability saga; Apex fights to get respiratory masks back in Germany; St. Jude and Volcano call a cease-fire

Boston Scientific reveals federal probe of BridgePoint buy, sales

August 7, 2014 by Arezu Sarvestani

Boston Scientific reveals federal probe of 2012 Bridgepoint Medical buy
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp